ReNeuron cleared to proceed with groundbreaking stem cell study

An independent monitoring board has given ReNeuron a green light to continue with a pioneering study in which stem cells are being injected into the brains of stroke victims. After reviewing the responses of the first three patients, the biotech will now try a higher dose. "Data from the laboratory safety tests, neurological examinations and neurofunctional tests conducted thus far indicate that the ReN001 treatment is safe and well-tolerated at the initial dose," said the U.K. company. Story

Suggested Articles

Panelists at the CAR-TCR Summit reflected on gender diversity trends and the challenges women face in the life sciences industry.

Loh joins the computational chemistry specialist after a two-year stint at Kymera Therapeutics.

The $3 billion funding boost includes an additional $350 million for targeted Alzheimer’s research.